Wells Fargo
CELU icon

Wells Fargo’s Celularity CELU Stock Holding History

Wells Fargo’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5K Hold
2,500
– – ﹤0.01% 6400
2026
Q1 		$3.33K Hold
2,500
– – ﹤0.01% 6192
2025
Q4 		$2.77K Buy
2,500
+2,000
+400% +$3.59K ﹤0.01% 6186
2025
Q3 		$1.03K Buy
+500
New +$1.4K ﹤0.01% 6250
2024
Q2 		– Sell
-1,107
Closed -$5.79K – 6975
2024
Q1 		$5.79K Buy
1,107
+22
+2% +$90 ﹤0.01% 5862
2023
Q4 		$2.69K Buy
1,085
+5
+0.5% +$11 ﹤0.01% 6050
2023
Q3 		$2.4K Buy
1,080
+15
+1% +$54 ﹤0.01% 6068
2023
Q2 		$5.67K Sell
1,065
-1,160
-52% -$7.43K ﹤0.01% 6055
2023
Q1 		$13.8K Buy
2,225
+1,216
+121% +$9.79K ﹤0.01% 5751
2022
Q4 		$13K Sell
1,009
-109
-10% -$2.01K ﹤0.01% 5445
2022
Q3 		$26K Buy
1,118
+1,084
+3,188% +$32.9K ﹤0.01% 5264
2022
Q2 		$1K Buy
+34
New +$2.76K ﹤0.01% 6475

Other funds holding CELU

CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

Wells Fargo's CELU Position: Q2 2026 in Review

Wells Fargo held its Celularity (CELU) position steady in Q2 2026 at 2,500 shares worth $1.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6400.

Wells Fargo first reported a position in CELU in Q2 2022 and has held it in 12 quarters since. The position peaked at $26K in Q3 2022. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

  • Wells Fargo held 2,500 shares of Celularity worth $1.5K as of Q2 2026.
  • Wells Fargo left its Celularity share count unchanged in Q2 2026.
  • Celularity made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6400 holding.
  • Wells Fargo first reported a position in Celularity in Q2 2022 and has held it in 12 quarters since.
  • Wells Fargo's Celularity position peaked at $26K in Q3 2022.
  • 39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.